APP/PS1 mice
Respiratory infection promotes T cell infiltration and Aβ deposition in APP/PS1 mice
46
Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice
13
Rosiglitazone improves spatial memory and decreases insoluble A?(1 42) in APP/PS1 mice
9
Minor ginsenoside F1 improves memory in APP/PS1 mice
8
Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits
16
Original Article Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer’s disease
14
Rescue of cognitive deficits in APP/PS1 mice by accelerating the aggregation of β-amyloid peptide
16
Electroacupuncture ameliorate learning and memory by improving N-acetylaspartate and glutamate metabolism in APP/PS1 mice
10
Amyloid β-induced impairments on mitochondrial dynamics, hippocampal neurogenesis, and memory are restored by phosphodiesterase 7 inhibition
15
Neuroprotective effects of D-Ala2GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model
24
Alzheimer’s disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression
17
Serotonin augmentation therapy by escitalopram has minimal effects on amyloid-β levels in early-stage Alzheimer’s-like disease in mice
12
Soluble epoxide hydrolase modulates immune responses in activated astrocytes involving regulation of STAT3 activity
16
Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment
12
URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer’s disease
14
Jujuboside A promotes Aβ clearance and ameliorates cognitive deficiency in Alzheimer's disease through activating Axl/HSP90/PPARγ pathway
17
Environmental novelty exacerbates stress hormones and Aβ pathology in an Alzheimer’s model
7
Transition from an M1 to a mixed neuroinflammatory phenotype increases amyloid deposition in APP/PS1 transgenic mice
11
Ca2+-dependent endoplasmic reticulum stress correlation with astrogliosis involves upregulation of KCa3.1 and inhibition of AKT/mTOR signaling
17
APOE4 mediated amyloid β pathology depends on its neuronal receptor LRP1
7